ClinicalTrials.gg

Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics clinical trials

A subsidiary of Structure Therapeutics

The registry lists 1 studies whose lead sponsor is Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 14, 2026.

Coming up

1 of Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics’ studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 1 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1100%

Phase

  • Phase 21
  • Phase 11

Where

  • United States1

Over the years

  1. 125
  2. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics1 study

Something wrong with this grouping? Tell us on the Structure Therapeutics page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Structure Therapeutics studies →